Skip to main content

Advertisement

SpringerLink
Log in

Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls

  • Original Paper
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Abstract

Patients with schizophrenia are at increased risk of diabetes, cardiovascular disease (CVD) and associated mortality versus the general population. Increased intra-abdominal and pericardial adipose tissue are associated with elevated CVD and mortality in the general population, but little is known about these in patients with schizophrenia. This study examined pericardial and intra-abdominal adipose tissue in schizophrenia and compared this to healthy controls. Thirty-one patients with schizophrenia (mean age 41.2 years, 76% males) and 30 healthy volunteers (CTRL) were examined in this study. The primary outcomes were the volumes of pericardial adipose tissue and intra-abdominal adipose tissue, measured using magnetic resonance imaging. Secondary outcomes included diabetes and cardiac event risk assessed by established instruments. Volumes of pericardial adipose tissue were increased in male and female patients with schizophrenia compared to healthy controls after the adjustment of age, sex and body mass index (P < 0.005). The 10-year risk of a cardiac event was significantly higher in patients with schizophrenia. Furthermore, the risk for developing type-2 diabetes mellitus was slightly increased in schizophrenia. Volumes of intra-abdominal adipose tissue were slightly increased in male and female patients with schizophrenia, albeit not statistically significant. This study demonstrates that patients with schizophrenia have increased pericardial adipose tissue versus controls. This increased fat deposit around the heart is highly relevant for understanding the comorbidity between heart disease and schizophrenia. Interventions aiming to reduce pericardial and intra-abdominal adipose tissue, such as exercise, may be essential to reduce the burden of heart disease in schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Alexopoulos N, Katritsis D, Raggi P (2014) Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis 233(1):104–112

    Article  PubMed  CAS  Google Scholar 

  2. Atkins JL, Whincup PH, Morris RW, Lennon LT, Papacosta O, Wannamathee SG (2014) Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men. J Am Geriatr Soc 62(2):253–260

    Article  PubMed  Google Scholar 

  3. Björntorp P, Rosmond R (1999) Visceral obesity and diabetes. Drugs 58(Suppl 1):13–18

    Article  PubMed  Google Scholar 

  4. Chen DC, Zhou MA, Zhou DH, Xiu MH, Wu GY, Kosten et al (2011) Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics. Psychiatry Res 186(2–3):451–453

    Article  PubMed  CAS  Google Scholar 

  5. Correll CU, Solmi M, Veronese N, Bortolato B, Santonastaso P, Thapa-Chhetri N et al (2017) Prevalence, incidence and mortality from cardovascular disease in patients with pooled and specific severe mental illness: a large scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16(2):163–180

    Article  PubMed  PubMed Central  Google Scholar 

  6. Cuppett M, Latin RW (2002) A survey of physical activity levels of certified athletic trainers. J Athl Train 37(3):281–285

    PubMed  PubMed Central  Google Scholar 

  7. De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller H-J (2009) Cardiovascular disease and diabetes in patients with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24(6):412–424

    Article  PubMed  Google Scholar 

  8. Ding J, Hsu F-C, Harris TB, Liu Y, Kritchevsky SB, Szklo M et al (2009) The association of pericardial fat with incident coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 90(3):499–504

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Fan Z, Wu Y, Shen J, Ji T, Zhan R (2013) Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies. J Psychiatr Res 47(11):1549–1556

    Article  PubMed  Google Scholar 

  10. Galling B, Roldán A, Nielsen RE, Nielsen J, Gerhard T, Carbon M et al (2016) Type 2 diabetes mellitus in youth exposed to antipsychotics: a systematic review and meta-analysis. JAMA Psychiatry 73(3):247–259

    Article  PubMed  Google Scholar 

  11. Gilles M, Hentschel F, Paslakis G, Glahn V, Lederbogen F, Deuschle M (2010) Visceral and subcutaneous fat in patients treated with olanzapine: a case series. Clin Neuropharmacol 33(5):248–249

    Article  PubMed  Google Scholar 

  12. Heald A, Pendlebury J, Anderson S, Narayan V, Guy M, Gibson M et al (2017) Lifestyle factors and the metabolic syndrome in Schizophrenia: a cross-sectional study. Ann Gen Psychiatry 16:12

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hyuk Kim T, Hoon Yu S, Hee Choi S, Won Yoon J, Mee Kang S, Ju Chun et al (2011) Pericardial fat amount is an independent risk factor of coronary artery stenosis assessed by multidetector-row computed tomography: The Korean Atherosclerosis Study 2. Obesity 19(5):1028–1034

    Article  Google Scholar 

  14. Iacobellis G, Singh N, Wharton S, Sharma AM (2008) Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity 16(7):1693–1697

    Article  PubMed  Google Scholar 

  15. Kahl KG, Hueper K, Schweiger U, Gutberlet M, Detlef A-M, Weiss C et al (2014) Pericardial, intra-abdominal, and subcutaneous adipose tissue in patients with major depressive disorder. Acta Psychiatr Scand 130(2):137–143

    Article  PubMed  CAS  Google Scholar 

  16. Kahl KG, Schweiger U, Correll C, Müller C, Busch ML, Bauer et al (2015) Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus. Brain Behav 5(3):e00306

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kahl KG, Kerling A, Tegtbur U, Gützlaff E, Herrmann J, Borchert L et al (2016) Effects of additional exercise training on epicardial, intra-abdominal and subcutaneous adipose tissue in major depressive disorder: a randomzied pilot study. J Affect Disord 1(192):91–97

    Article  Google Scholar 

  18. Katsiki N, Athyros VG, Mikhailidis DP (2016) Abnormal peri-organ or intra-organ fat (APIFat) deposition: an underestimated predictor of vascular risk? Curr Vasc Pharmacol 14(5):432–441

    Article  PubMed  CAS  Google Scholar 

  19. Kim M-K, Tomita T, Kim M-J, Sasai H, Maeda S, Tanaka K (2009) Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol 106(1):5–11

    Article  PubMed  Google Scholar 

  20. Konarzewska B, Stefańska E, Wendołowicz A, Cwalina U, Golonko A, Małus A et al (2014) Visceral obesity in normal-weight patients suffering from chronic schizophrenia. BMC Psychiatry 14:35

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R et al (2006) Visceral fat is an independent predictor of all-cause mortality in men. Obesity 14(2):336–341

    Article  PubMed  Google Scholar 

  22. Miao C, Chen S, Ding J, Liu K, Li D, Macedo R et al (2011) The association of pericardial fat with coronary artery plaque index at MR imaging: The Multi-Ethnic Study of Atherosclerosis (MESA). Radiology 261(1):109–111

    Article  PubMed  PubMed Central  Google Scholar 

  23. Misawa F, Shimizu K, Fujii Y, Miyata R, Koshiishi F, Kobayashi M et al (2011) Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study. BMC Psychiatry 11:118

    Article  PubMed  PubMed Central  Google Scholar 

  24. Mitchell AJ, Vancampfort D, Sweers K, Van Winkel R, Yu W, De Hert M (2013) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull 39(2):306–318

    Article  PubMed  Google Scholar 

  25. Nicklas BJ, Penninx BWJH, Cesari M, Kritchevsky SB, Newman AB, Kanaya AM et al (2004) Association of visceral adipose tissue with incident myocardial infarction in older men and women: the health, aging and body composition study. Am J Epidemiol 160(8):741–749

    Article  PubMed  Google Scholar 

  26. Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y et al (2007) Management of antipsychotic-incluced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Aust N Z J Psychiatry 41(12):980–989

    Article  PubMed  Google Scholar 

  27. Ryan MCM, Flanagan S, Kinsella U, Keeling F, Thakore JH (2004) The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci 74(16):1999–2008

    Article  PubMed  CAS  Google Scholar 

  28. Stubbs B, Firth J, Berry A, Schuch FB, Rosenbaum S, Gaughran F et al (2016) How much physical activity do patients with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression. Schizophr Res 176(2):431–440

    Article  PubMed  Google Scholar 

  29. Stubbs B, Williams J, Gaughran F, Craig T (2016) How sedentary are patients with psychosis? A systematic review and meta-analysis. Schizophr Res 171(1–3):103–109

    Article  PubMed  Google Scholar 

  30. Stubbs B, Vancampfort D, De Hert M, Mitchell AJ (2015) The prevalence and predictors of type two diabetes mellitus in patients with schizophrenia: a systematic review and comparative meta-analysis. Acta Psychiatr Scand 132(2):144–157

    Article  PubMed  CAS  Google Scholar 

  31. Tadros T, Massaro J, Rosito G, Hoffmann U, Vasan R, Larson M et al (2010) Pericardial fat volume correlates with inflammatory markers: The Framingham Heart Study. Obesity 18(5):1039–1045

    Article  PubMed  Google Scholar 

  32. Thakore JH, Mann JN, Vlahos I, Martin A, Reznek R (2002) Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 26(1):137–141

    Article  PubMed  CAS  Google Scholar 

  33. Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB et al (2015) Risk of metabolic syndrome and its components in patients with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry 14(3):339–347

    Article  PubMed  PubMed Central  Google Scholar 

  34. Vancampfort D, Correll CU, Galling B, Probst M, De Hert M, Ward PB et al (2016) Diabetes mellitus in patients with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry 15(2):166–174

    Article  PubMed  PubMed Central  Google Scholar 

  35. Vancampfort D, Rosenbaum S, Schuch F, Ward PB, Richards J, Mugisha J et al (2017) Cardiorespiratory fitness in severe mental illness: A Systematic Review and Meta-analysis. Sports Med 47(2):343–352

    Article  PubMed  Google Scholar 

  36. Walker ER, McGee RE, Druss BG (2015) Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry 72(4):334–341

    Article  PubMed  PubMed Central  Google Scholar 

  37. Wannamathee SG, Atkins JL (2015) Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc 74(4):405–412

    Article  Google Scholar 

  38. Willens HJ, Byers P, Chirinos JA, Labrador E, Hare JM, de Marchena E (2007) Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol 99(9):1242–1245

    Article  PubMed  Google Scholar 

  39. Yun CH, Lin TY, Wu YJ, Liu CC, Kuo JY, Yeh HI et al (2012) Pericardial and thoracic peri-aortic adipose tissue contributes to systemic inflammation and calcified coronary artherosclerosis independent of body fat composition, anthropometric measures and traditional cardiovascular risks. Eur J Radiol 81(4):749–756

    Article  PubMed  Google Scholar 

  40. Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V (2008) Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis 18(5):388–395

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. D. Hartung, J. Herrmann made equal contribution to the manuscript.

Authors and Affiliations

  1. Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School (MHH), Carl-Neuberg. Str. 1, 30625, Hannover, Germany

    J. Ruppert, J. Herrmann, T. H. C. Krüger & K. G. Kahl

  2. Institute for Diagnostic and Interventional Radiology, MHH, Hannover, Germany

    D. Hartung

  3. Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany

    M. Westhoff-Bleck

  4. Physiotherapy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, SE5 8AZ, UK

    B. Stubbs

  5. Health Service and Population Research Department, Institute of Psychiatry, King’s College London, London, UK

    B. Stubbs

  6. Department of Psychiatry and Psychotherapy, Heinrich-Heine University, Düsseldorf, Germany

    J. Cordes

  7. Institute for Clinical Chemistry, Hannover Medical School, Hannover, Germany

    R. Lichtinghagen

Authors
  1. J. Ruppert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Westhoff-Bleck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Stubbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Cordes
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. H. C. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Lichtinghagen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. K. G. Kahl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. G. Kahl.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ruppert, J., Hartung, D., Westhoff-Bleck, M. et al. Increased pericardial adipose tissue and cardiometabolic risk in patients with schizophrenia versus healthy controls. Eur Arch Psychiatry Clin Neurosci 268, 719–725 (2018). https://doi.org/10.1007/s00406-017-0858-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00406-017-0858-y

Keywords

Search

Navigation